Differential benefit of induction chemotherapy according to body mass index in nasopharyngeal carcinoma – Pooled analysis of two randomized trials

诱导化疗 医学 超重 内科学 体重不足 鼻咽癌 体质指数 析因分析 化疗 放化疗 随机对照试验 肿瘤科 外科 放射治疗
作者
Xu Liu,Wen‐Fei Li,Cong Ding,Lei Chen,Ying Sun,Jinghua Li,Jun Ma,Yuan Zhang
出处
期刊:Oral Oncology [Elsevier BV]
卷期号:125: 105718-105718 被引量:1
标识
DOI:10.1016/j.oraloncology.2022.105718
摘要

Induction chemotherapy followed by concurrent chemoradiotherapy is the standard of care for patients with locoregionally advanced nasopharyngeal carcinoma (NPC). However, survival benefits from additional induction chemotherapy varied significantly among patients. This study aimed to determine the predictive value of body mass index (BMI) in induction chemotherapy in NPC.This post-hoc analysis included patients from two multicenter, randomized, phase 3 trials (NCT01245959 and NCT01872962), in which patients were randomized to receive induction chemotherapy plus concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.Among 960 patients participated, 957 were included in this analysis. 82 (8.6%) patients had baseline BMI < 18.5 kg/m2 (underweight) and 875 (91.4%) had BMI ≥ 18.5 kg/m2 (normal /overweight). Higher proportion of normal/overweight patients completed ≥2 cycles of induction chemotherapy than underweight patients (96.5% vs. 88.4%, p = 0.042). A strong trend for interaction was observed between BMI and induction chemotherapy regarding failure-free survival (FFS) and overall survival (OS, both pinteraction < 0.001). Normal/overweight patients benefited from induction chemotherapy regarding FFS (83.8% vs. 72.9%, p < 0.001) or OS (93.1% vs. 86.9%, p < 0.001), while underweight patients did not (p = 0.24 and p = 0.65, respectively). These results were confirmed in multivariate analysis and multiple sensitivity analyses.Using pooled data from two landmark phase III trials, we found that underweight patients might not benefit from additional induction chemotherapy in locoregionally advanced NPC. If confirmed in prospective studies, this could help guide individual treatment in the clinic.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
fuje发布了新的文献求助10
1秒前
SYLH应助清脆的雁丝采纳,获得10
1秒前
Szhou完成签到,获得积分10
2秒前
为神指路发布了新的文献求助10
3秒前
4秒前
郑伟李完成签到,获得积分10
5秒前
嗯哼发布了新的文献求助10
7秒前
zzzxxxxxyyyyy给zzzxxxxxyyyyy的求助进行了留言
7秒前
Nicole发布了新的文献求助10
8秒前
9秒前
qqqqqq完成签到,获得积分10
10秒前
10秒前
Ava应助难过小懒虫采纳,获得10
12秒前
GT发布了新的文献求助10
13秒前
xphpyy完成签到,获得积分10
14秒前
14秒前
14秒前
15秒前
15秒前
16秒前
可乐加冰发布了新的文献求助10
16秒前
dliu201304发布了新的文献求助10
16秒前
18秒前
ddd发布了新的文献求助10
18秒前
19秒前
20秒前
徐小徐完成签到,获得积分10
20秒前
IAMXC发布了新的文献求助10
20秒前
20秒前
二丙发布了新的文献求助10
20秒前
21秒前
Wone发布了新的文献求助10
22秒前
66发布了新的文献求助10
22秒前
dzy1317完成签到,获得积分10
23秒前
ttttt发布了新的文献求助10
23秒前
SHEN关注了科研通微信公众号
23秒前
研友_8oYMyn发布了新的文献求助10
24秒前
hy应助ddd采纳,获得10
25秒前
何敏娟发布了新的文献求助10
25秒前
kleine完成签到 ,获得积分10
26秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976210
求助须知:如何正确求助?哪些是违规求助? 3520366
关于积分的说明 11203088
捐赠科研通 3256965
什么是DOI,文献DOI怎么找? 1798570
邀请新用户注册赠送积分活动 877738
科研通“疑难数据库(出版商)”最低求助积分说明 806516